$AIP

Alpern Paul L sold $141K of AIP

Alpern Paul L (VP and General Counsel) sold 3,648 shares of Arteris, Inc. (AIP) at $38.78 ($0.14M total) across 4 trades on 2026-07-02.

Original reporting
SEC EDGAR · Alpern Paul L
Published Jul 6, 2026, 9:25 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 6, 2026, 9:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AIP
Neutral
high confidence
Mentioned
$AIP
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AIPNeutralLow
01

Why it matters

The newest fact is the disclosed open-market sale by the company’s VP & General Counsel (3,648 shares; ~$141.5K) executed July 2 and reported via an EDGAR filing on July 6.

02

Market read

Traders may monitor insider activity for sentiment, but the filing lacks any accompanying fundamental catalyst.

03

What to watch

The article provides only sale details (size, price, post-holdings) and no context on liquidity needs, diversification, or tax planning, which can dominate interpretation.

Relevance 4/10Novelty 3/10Timing: Filed July 6 after July 2 insider sale execution.

Background

This is an SEC Form 4 insider transaction disclosure for Arteris, Inc. (AIP).

Company-level read

Ticker impact

$AIPNeutralHigh confidence
Context

Arteris Form 4 shows VP & General Counsel Alpern Paul L sold 3,648 shares for about $141.5K on July 2 at $38.7779.

Expected impact

Low near-term impact; any effect is likely sentiment-only and short-lived.

Evidence & confidence

The filing is a Form 4 insider transaction with no 10b5-1 plan and no accompanying company-specific operational/regulatory catalyst in the text.

Market effects

No sector read-through provided; this is company-specific insider activity only.

None indicated.

None indicated.

Counterpoint

Because the sale is not explicitly tied to a 10b5-1 plan, some traders may interpret it as a stronger negative signal than typical scheduled selling.

Key entities

  • Arteris, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Alpern Paul L

    VP and General Counsel who sold shares in open-market transactions.

Related articles

MedAI 8/10

Arteris Inc. raises FY26 sales guidance to $95-98M range

Arteris Inc. raised its FY2026 revenue guidance to $95.0 million to $98.0 million, up from $91.0 million to $95.0 million previously. The new range is above the $94.578 million analyst consensus estimate, reflecting stronger-than-expected demand for its NoC interconnects and design automation tools, according to the company.

$AIPHighAI 9/10

Arteris, Inc. (AIP): Results of Operations and Financial Condition

Arteris, Inc. (AIP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991q2fy268-k.htm EX-99.1 Document Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance CAMPBELL, Calif. - August 6, 2026 - Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor techn